Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1038/s41598-017-03675-z
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2017
- Urheber
-
Cabrera, Daniel
Wree, Alexander
Povero, Davide
Solís, Nancy
Hernandez, Alejandra
Pizarro, Margarita
Moshage, Han
Torres, Javiera
Feldstein, Ariel E.
Cabello-Verrugio, Claudio
Brandan, Enrique
Barrera, Francisco
Arab, Juan Pablo
Arrese, Marco
- DOI
-
10.18154/RWTH-CONV-221678
- URN
-
urn:nbn:de:101:1-2020081313163149141532
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cabrera, Daniel
- Wree, Alexander
- Povero, Davide
- Solís, Nancy
- Hernandez, Alejandra
- Pizarro, Margarita
- Moshage, Han
- Torres, Javiera
- Feldstein, Ariel E.
- Cabello-Verrugio, Claudio
- Brandan, Enrique
- Barrera, Francisco
- Arab, Juan Pablo
- Arrese, Marco
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2017
Ähnliche Objekte (12)
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
Analysis of non-alcoholic beverages
L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
Analysis of non-alcoholic beverages
L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
Analysis of non-alcoholic beverages